Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The effects of glucagon-like peptide 1 receptor agonist (exenatide) on memory impairment, and anxiety- and depression-like behavior induced by REM sleep deprivation
In patients with type 2 diabetes, treatment with semaglutide 1 mg resulted in reductions in glucose in terms of absolute change from baseline and relative reduction compared to placebo of 29 mg/dL (22%) for fasting glucose, 74 mg/dL (36%) for 2 hour postprandial glucose, and 30 mg/dL (22%) for mean 24 hour glucose concentration (see Figure 1)
Optimize injection technique by following the manufacturer's Instructions for Use
Even after biosimilar entry in early 2023, AbbVie preserved substantial formulary share through a dual strategy
US$ 21.02
US$ 23.23
US$ 21.85
US$ 22.27
US$ 27.42
